Seely Lynninsider trades
In SEC Form 4 filings, Seely Lynn is listed as President and CEO of Lyell Immunopharma, Inc. (LYEL). In the last 90 days, Seely Lynn sold $149K of Lyell Immunopharma, Inc. (LYEL) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| LYELLyell Immunopharma, Inc. | President and CEO | 1 | Aug 25 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-25
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.